Logo

Millipore Posts 40-Percent Gain in Q1 Sales, Though Profits Sink 23 Percent

May 03, 2007
NEW YORK (GenomeWeb News) — Millipore yesterday said first-quarter revenues increased 39 percent as R&D spending rose 50 percent and profit slid 23 percent.
 
Total receipts for the three months ended March 31 increased to $372 million from $268.4 million year over year.
 
Sales in the company’s Bioprocess segment rose 40 percent to $214.3 million, while Bioscience revenue swelled 51 percent to $157.7 million.
 
In a statement, CEO Martin Madaus said demand was strong for its drug-related and vaccine-related consumables in the Bioprocess division, and the Bioscience division is focused on integrating Serologicals, which the company acquired last summer.
  
R&D spending increased to $27.5 million from $18.4 million year over year.
 
The company said profits fell to $26.7 million from $34.5 million in the year-ago period.
 
Millipore said it had around $56.6 million in cash and cash equivalents as of March 31.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.